Saudi Food and Drug Authority - Regulatory authority for pharmaceuticals and medical devices in Saudi Arabia
显示 2024 年的审批记录
仅限当前页。暂不支持搜索完整审批数据集。
药物名称 | 公司 | 适应症 | 日期 | 类型 |
|---|---|---|---|---|
| sirolimus | Novitium Pharma LLC | Oral solution | Jan 1, 2024 | Generic |
| Tugatev | Sofarimex Indústria Química e Farmacêutica, S.A.. | Powder for solution for infusion | Jan 1, 2024 | Generic |
| TACROZ Forte | Glenmark Pharmaceuticals Limited - Baddi | Ointment | Jan 1, 2024 | Generic |
| ELZONRIS | Alcami Carolinas Corporation | Injection | Jan 1, 2024 | Biological |
| PROVINDA PLUS | SPIMACO | Tablet | Jan 1, 2024 | Generic |
| Malaquon | Hetero Labs Limited Unit – V | Tablet | Jan 1, 2024 | Generic |
| Sita | Alrai Pharmaceutical industry Co. (L.L.C) | Film-coated tablet | Jan 1, 2024 | Generic |
| Hyponal | Egyptian International Pharmaceutical Industries Company (EIPICO) | Solution for injection | Jan 1, 2024 | Generic |
| PROVINDA PLUS | SPIMACO | Tablet | Jan 1, 2024 | Generic |
| Sita | Alrai Pharmaceutical industry Co. (L.L.C) | Film-coated tablet | Jan 1, 2024 | Generic |
| Levogand | Acme Generics LLP | Tablet | Jan 1, 2024 | Generic |
| Trisuva | Lyocontract GmbH | Infusion | Jan 1, 2024 | Generic |
| Ultasil | ALTERGON ITALIA S.r.l | Orodispersible film | Jan 1, 2024 | NCE |
| Trisuva | Lyocontract GmbH | Infusion | Jan 1, 2024 | Generic |
| Concentia | Laboratorios Liconsa S.A | Prolonged-release tablet | Jan 1, 2024 | Generic |
| Concentia | Laboratorios Liconsa S.A | Prolonged-release tablet | Jan 1, 2024 | Generic |
| Trovapt | APOTEX INC. (SIGNET SITE) | Tablet | Jan 1, 2024 | Generic |
| Nuvessa | Laboratories Liconsa SA | Gel | Jan 1, 2024 | NCE |
| Rezurock | UPM Pharmaceuticals | Film-coated tablet | Jan 1, 2024 | NCE |
| Mictonorm XL | LOSAN PHARMA GMBH | Modified-release capsule, hard | Jan 1, 2024 | NCE |
